Clinical Trial

Chemoradiotherapy for Advanced Esophageal Cancer

Study acronym: PaRCUS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to show that the addition of carboplatin and paclitaxel chemotherapy to a palliative course of external beam radiation treatment improves both dysphagia relief and patient quality of life in patients with unresectable esophageal cancer.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2014-11-20; most recent amendment 2025-12-09.
Status change: Not Yet Recruiting → Recruiting 2020-11-03
Trial Details
NCT Number NCT02297217
Lead Sponsor AHS Cancer Control Alberta
Conditions Esophageal Cancer
Enrollment 50 participants
Start Date 2019-11-21
Primary Completion 2027-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-16